| Powder: | Yes |
|---|---|
| Customized: | Customized |
| Certification: | GMP, HSE, ISO 9001, USP, BP |
| Suitable for: | Elderly, Children, Adult |
| State: | Powder |
| Purity: | >99% |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier
Lapatinib, used in the form of Lapatinib Ditosylate, is a potent EGFR and ErbB2 inhibitor with IC50 of 10.8 and 9.2 nM in cell-free assays, respectively.
Lapatinib is used as a treatment for women's breast cancer in treatment naive, ER+/EGFR+/HER2+ breast cancer patients(now often called "triple positive") and in patients who have HER2-positive advanced breast cancer that has progressed after previous treatment with other chemotherapeutic agents, such as anthracycline, taxane-derived drugs, or trastuzumab (Herceptin, Genentech).
| Items | Specifications | Results |
| Appearance | White powder | Conforms |
| Melting point | 245ºC~255ºC | 245.5ºC~247.6ºC |
| Total impurities | ≤1.0% | 0.79% |
| Loss on drying | ≤1.0% | 0.2% |
| Heavy metals | ≤20ppm | Conforms |
| Assay | ≥99.0% | 99.21% |
| Conclusion: passed. | ||
| Abaloparatide | octenidine dihydrochloride | ABT-263 |
| Abemaciclib | O-Desmethylgefitinib | ABT-737 |
| Abiraterone | Osimertinib Mesylate | AZD0328 |
| acalabrutinib | Pacritinib | AZD1236 |
| ALTIRATINIB | Pazopanib HCL | AZD-1480 |
| amfonelic acid | Peficitinib | AZD1656 |
| Anlotinib | Pegdinetanib | AZD1775 |
| Asciminib | ponatinib | AZD1981 |
| Atipamezole HCl | Pyrotinib | AZD2014 |
| Atuveciclib | R788(FOSTAMATINIB DISODIUM) | AZD4017 |
| AV-951 | Radotinib | AZD4573 |
| Avapritinib | ramelteon | AZD5069 |
| Axitinib | Refametinib | AZD5153 |
| Bafetinib | Ribociclib | AZD5213 |
| bendamustine hydrochloride | Riviciclib hydrochloride | AZD5904 |
| Binimetinib | ruxolitinib | AZD7325 |
| Bosutinib | Saracatinib | AZD9150 |
| brigatinib | Savolitinib | Batimastat |
| Cabozantinib | Semaxanib | BMS202 |
| Cabozantinib Maleate | Simotinib HCl | BMS-214662 |
| Capmatinib | Solcitinib | Carfilzomib |
| Cediranib | Sonolisib | CEP-40783 |
| Cerdulatinib | Sulfatinib | CO-1686 |
| Chiauranib | sunitinib | darolutamide |
| Cinchocaine HCL | Sunitinib Maleate | EDO-S101 |
| Cipatinib | Teniposide | emodepside |
| Cobimetinib | Toceranib | EPZ-6438 |
| Dacomitinib | Tofacitinib citrate | IPI-145 |
| dasatinib | trametinib | LDE225 HCL |
| Decernotinib | Vandetanib | MK2206 |
| Donafenib | Volitinib | OSI-027 |
| dovitinib | Voruciclib hydrochloride | OTSSP167 |
| E7449 | WORTMANNIN | PD 98059 |
| Entospletinib | Zibotentan(ZD4054) | PF-04691502 |
| Erdafitinib | zuclopenthixol | PI-103 |
| Erlotinib | larotrectinib | PLX3397 |
| etoposide | Lerociclib dihydrochloride | PLX4720 |
| Famitinib | Lesogaberan AZD3355 | PP-121 |
| Filgotinib | levatinib | PQR309/Bimiralisib |
| Firocoxib | Lorlatinib | Sapanisertib |
| Flumatinib | Maraviroc | selinexor |
| Foretinib | Masitinib mesylate | S-Ruxolitinib |
| Fostamatinib | Mocetinostat | TAE684 |
| Fruquintinib | neratinib | Tafamidis |
| Gefitinib | tenapanor | |
| Gilteritinib | Verteporfin | |
| Golvatinib | WYE-354 | |
| Henatinib | WYE-687 | Atezolizumab |
| Icotinib | 4-IPP | Avelumab |
| imatinib | A-770041 | Durvalumab |
| imatinib mesylate | MLN4924 | Pembrolizumab |
| Lapatinib | OTX-015 | Pertuzumab |
| lapatinib ditosylate | PLX3397 Pexidartinib | Ramucirumab |
| Midostaurin | WAY-600 | |
| nilotinib | WEHI-539 | |
| Oclacitinib maleate | WYE-125132 |
| Shipping Terms | ||
| By Express | By Air | By Sea |
| Suitable for under 50kg Fast:3-4 days High cost Door to door service Easy to pick up the goods |
Suitable for more than 50kg Fast:3-4 days High cost Airport to airport Professional broker needed |
Suitable for more than 500kg Slow:15-30 days Low cost Port to port Professional broker needed |
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}